CAUSES OF DYSMETABOLIC NEPHROPATHY IN CHILDREN
Keywords:
Dysmetabolic nephropathy, children, crystalluria, oxalate metabolism, pediatric nephrology, metabolic disorders, urinary tract infections, nephrocalcinosis, kidney disease, oxidative stress, hereditary predisposition, renal pathology, urinary syndrome, pediatric urology.Abstract
This article examines the etiological factors, pathogenic mechanisms, clinical manifestations, and diagnostic features of dysmetabolic nephropathy in children. The study analyzes the role of hereditary predisposition, metabolic disorders, nutritional imbalance, environmental influences, and urinary tract infections in the development of renal pathology. Clinical, laboratory, and ultrasound investigations were conducted to evaluate metabolic disturbances and identify the main risk factors associated with pediatric dysmetabolic nephropathy. The results demonstrated that oxalate-crystalluria, insufficient fluid intake, unhealthy dietary habits, and recurrent infections significantly contribute to disease progression. The study emphasizes the importance of early diagnosis, preventive measures, dietary correction, and комплекс management in reducing complications and preventing chronic kidney disease in children.
References
1.Stapleton FB. Clinical approach to children with urolithiasis. Seminars in Nephrology. 2016;16(5):389–397.
2.Eddy AA, Symons JM. Nephrotic syndrome in childhood. The Lancet. 2018;362(9384):629–639.
3.Coe FL, Evan A, Worcester E. Kidney stone disease. The Journal of Clinical Investigation. 2005;115(10):2598–2608.
4.Santos F, Malaga S, Cobo A. Metabolic disorders and nephropathy in children. International Journal of Nephrology. 2020;2020:1–9.
5.Avner ED, Harmon WE, Niaudet P, Yoshikawa N. Pediatric Nephrology. Berlin: Springer; 2016.
6.Hoppe B, Leumann E. Diagnostic and therapeutic approaches in children with hyperoxaluria. Pediatric Nephrology. 2007;22(10):1589–1599.
7.Hogg RJ. Evaluation and management of pediatric nephrolithiasis. Current Opinion in Pediatrics. 2019;31(2):252–257.
8.Gearhart JP, Herzberg GZ, Jeffs RD. Childhood urolithiasis: experiences and advances. Pediatrics. 2017;87(4):445–450.
9.Copelovitch L. Urolithiasis in children: medical approach. Pediatric Clinics of North America. 2012;59(4):881–896.
10.Stapleton FB. Childhood stones. Endocrinology and Metabolism Clinics of North America. 2002;31(4):1001–1015.
11.Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clinical Journal of the American Society of Nephrology. 2011;6(8):2062–2068.
12.Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clinic Proceedings. 1993;68(3):241–248.
13.Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatric Nephrology. 2010;25(3):403–413.
14.Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Translational Andrology and Urology. 2014;3(3):256–276.
15.Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. The New England Journal of Medicine. 2010;363(10):954–963.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal